Prialt Overview
- Status
-
Acquired/Merged
- Employees
-
34
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
Prialt General Information
Description
Developer of a non-opioid intrathecal therapy designed to reduce severe chronic pain in adult patients. The company's medicines work on pain transmission by binding to the N-type calcium channels in the spinal cord that send pain signals, enabling patients to reduce chronic pain.
Contact Information
Website
www.prialt.com(Operating Subsidiary)
Corporate Office
- United States
Corporate Office
- United States
Prialt Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Prialt Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Prialt Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Prialt FAQs
-
Where is Prialt headquartered?
Prialt is headquartered in .
-
What is the size of Prialt?
Prialt has 34 total employees.
-
What industry is Prialt in?
Prialt’s primary industry is Drug Discovery.
-
Is Prialt a private or public company?
Prialt is a Private company.
-
What is the current valuation of Prialt?
The current valuation of Prialt is 0000.
-
What is Prialt’s current revenue?
The current revenue for Prialt is 00000.
-
Who are Prialt’s investors?
Elan and Jazz Pharmaceuticals have invested in Prialt.
-
When was Prialt acquired?
Prialt was acquired on 27-Sep-2018.
-
Who acquired Prialt?
Prialt was acquired by TerSera Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
